INNOSPEC INC. - Quarter Report: 2016 September (Form 10-Q)

INNOSPEC INC. - Quarter Report: 2016 September (Form 10-Q)

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2016

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 1-13879

INNOSPEC INC.

(Exact name of registrant as specified in its charter)


DELAWARE		98-0181725
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

8310 South Valley Highway
Suite 350
Englewood
Colorado		80112
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (303) 792 5554

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.


Class		Outstanding as of October 28, 2016
Common Stock, par value $0.01		23,982,705

TABLE OF CONTENTS


PART I	FINANCIAL INFORMATION	4

Item 1	Financial Statements	4
	Consolidated Statements of Income	4
	Consolidated Statements of Comprehensive Income	5
	Consolidated Balance Sheets	6
	Consolidated Balance Sheets (continued)	7
	Consolidated Statements of Cash Flows	8
	Consolidated Statement of Equity	9
	Notes To The Unaudited Interim Consolidated Financial Statements	10
Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Three and Nine Months Ended September 30, 2016	22
	Critical Accounting Estimates	22
	Results of Operations	22
	Liquidity and Financial Condition	31
Item 3	Quantitative and Qualitative Disclosures about Market Risk	32
Item 4	Controls and Procedures	33

PART II	OTHER INFORMATION	33

Item 1	Legal Proceedings	33
Item 1A	Risk Factors	33
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	34
Item 3	Defaults Upon Senior Securities	34
Item 4	Mine Safety Disclosures	34
Item 5	Other Information	34
Item 6	Exhibits	34

SIGNATURES		35

CAUTIONARY STATEMENT RELATIVE TO FORWARD-LOOKING STATEMENTS

This Form 10-Q contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like “expects,” “estimates,” “anticipates,” “may,” “believes,” “feels” or similar words or expressions, for example,) which relate to earnings, growth potential, operating performance, events or developments that we expect or anticipate will or may occur in the future. Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements. Additional information regarding risks, uncertainties and assumptions relating to Innospec and affecting our business operations and prospects are described in Innospec’s Annual Report on Form 10-K for the year ended December 31, 2015, Innospec’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2016 and other reports filed with the U.S. Securities and Exchange Commission. You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading “Risk Factors” in such reports. Innospec undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

PART I

FINANCIAL INFORMATION

Item 1

Financial Statements

INNOSPEC INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)


	Three Months Ended September 30						Nine Months Ended September 30
(in millions, except share and per share data)	2016			2015			2016			2015
Net sales	$	205.5		$	254.2		$	645.6		$	766.3
Cost of goods sold		(126.3	)		(163.8	)		(404.7	)		(506.6	)

Gross profit		79.2			90.4			240.9			259.7
Operating expenses:
Selling, general and administrative		(56.1	)		(52.7	)		(153.1	)		(151.6	)
Research and development		(6.5	)		(6.6	)		(19.6	)		(19.3	)
Adjustment to fair value of contingent consideration		2.3			8.5			6.3			31.6
Profit/(loss) on disposal of subsidiary		0.0			1.6			(1.4	)		1.6

Total operating expenses		(60.3	)		(49.2	)		(167.8	)		(137.7	)

Operating income		18.9			41.2			73.1			122.0
Other net (expense)/income		(5.0	)		1.2			3.2			(2.0	)
Interest expense, net		(0.7	)		(1.0	)		(2.2	)		(2.9	)

Income before income taxes		13.2			41.4			74.1			117.1
Income taxes		(1.8	)		(5.8	)		(14.9	)		(29.1	)

Net income	$	11.4		$	35.6		$	59.2		$	88.0


Earnings per share:
Basic	$	0.48		$	1.48		$	2.47		$	3.64

Diluted	$	0.47		$	1.45		$	2.42		$	3.57


Weighted average shares outstanding (in thousands):
Basic		23,977			24,121			23,989			24,162

Diluted		24,476			24,611			24,462			24,660

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

INNOSPEC INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)


	Three Months Ended September 30						Nine Months Ended September 30
(in millions)	2016			2015			2016			2015
Net income	$	11.4		$	35.6		$	59.2		$	88.0

Other comprehensive income/(loss):
Changes in cumulative translation adjustment		(0.1	)		5.1			(0.3	)		0.4
Amortization of prior service credit, net of tax of $0.0 million, $0.1 million, $0.1 million and $0.2 million, respectively		(0.2	)		(0.2	)		(0.7	)		(0.7	)
Amortization of actuarial net losses, net of tax of $(0.1) million, $(0.2) million, $(0.4) million and $(0.8) million, respectively		0.5			1.1			1.6			3.1

Total other comprehensive income		0.2			6.0			0.6			2.8

Total comprehensive income	$	11.6		$	41.6		$	59.8		$	90.8

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

INNOSPEC INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS


(in millions, except share and per share data)	September 30, 2016			December 31, 2015
	(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	167.1		$	136.9
Short-term investments		0.0			4.8
Trade and other accounts receivable (less allowances of $4.4 million and $3.6 million, respectively)		125.5			137.4
Inventories (less allowances of $8.4 million and $8.8 million, respectively):
Finished goods		109.5			104.4
Work in progress		0.8			2.7
Raw materials		51.5			52.8

Total inventories		161.8			159.9
Current portion of deferred tax assets		8.6			8.8
Prepaid expenses		9.2			6.1
Prepaid income taxes		7.0			3.0
Other current assets		0.0			1.8

Total current assets		479.2			458.7
Property, plant and equipment:
Gross cost		174.5			161.0
Less accumulated depreciation		(94.3	)		(85.0	)

Net property, plant and equipment		80.2			76.0
Goodwill		267.4			267.4
Other intangible assets		150.5			168.7
Deferred finance costs		1.2			1.4
Deferred tax assets, net of current portion		1.4			1.4
Pension asset		62.6			55.5
Other non-current assets		0.8			0.9

Total assets	$	1,043.3		$	1,030.0

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

INNOSPEC INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS - (Continued)


(in millions, except share and per share data)	September 30, 2016			December 31, 2015
	(Unaudited)
Liabilities and Equity
Current liabilities:
Accounts payable	$	56.4		$	52.2
Accrued liabilities		79.7			84.1
Current portion of finance leases		1.6			0.7
Current portion of plant closure provisions		5.0			6.4
Current portion of accrued income taxes		11.8			7.9
Current portion of acquisition-related contingent consideration		4.3			54.6
Current portion of deferred income		0.2			0.2

Total current liabilities		159.0			206.1
Long-term debt, net of current portion		143.0			133.0
Finance leases, net of current portion		2.9			2.4
Plant closure provisions, net of current portion		34.2			31.3
Unrecognized tax benefits, net of current portion		2.3			3.9
Deferred tax liabilities, net of current portion		38.2			37.7
Pension liability		10.0			9.2
Deferred income, net of current portion		0.6			0.6
Other non-current liabilities		0.9			0.5

Total liabilities		391.1			424.7

Equity:
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares		0.3			0.3
Additional paid-in capital		313.4			311.0
Treasury stock (5,572,705 and 5,453,078 shares at cost, respectively)		(99.0	)		(91.8	)
Retained earnings		547.5			496.4
Accumulated other comprehensive loss		(110.3	)		(110.9	)

Total Innospec stockholders’ equity		651.9			605.0
Non-controlling interest		0.3			0.3

Total equity		652.2			605.3

Total liabilities and equity	$	1,043.3		$	1,030.0

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

INNOSPEC INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


	Nine Months Ended September 30
(in millions)	2016			2015
Cash Flows from Operating Activities
Net income	$	59.2		$	88.0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		28.5			25.7
Adjustment to fair value of contingent consideration		(6.3	)		(31.6	)
Deferred taxes		0.5			13.9
Excess tax benefit from stock-based payment arrangements		(0.2	)		(0.7	)
Loss/(profit) on disposal of subsidiary		1.4			(1.6	)
Cash contributions to defined benefit pension plans		(0.8	)		(7.9	)
Non-cash movements on defined benefit pension plans		(4.7	)		0.4
Stock option compensation		2.8			2.7
Changes in assets and liabilities, net of effects of acquired and divested companies:
Trade and other accounts receivable		12.3			21.2
Inventories		(1.0	)		0.8
Prepaid expenses		(3.0	)		4.0
Accounts payable and accrued liabilities		(1.0	)		(21.6	)
Accrued income taxes		(0.9	)		0.8
Plant closure provisions		1.5			1.4
Unrecognized tax benefits		(1.6	)		(2.6	)
Other non-current assets and liabilities		0.1			(2.3	)

Net cash provided by operating activities		86.8			90.6

Cash Flows from Investing Activities
Capital expenditures		(12.2	)		(12.0	)
Proceeds from disposal of subsidiary		0.0			41.5
Business combinations, net of cash acquired		1.8			0.0
Internally developed software		0.0			(7.0	)
Purchase of short-term investments		0.0			(5.3	)
Sale of short-term investments		4.7			4.8

Net cash (used in)/provided by investing activities		(5.7	)		22.0

Cash Flows from Financing Activities
Non-controlling interest		0.0			0.4
Proceeds from revolving credit facility		28.0			0.0
Repayments of revolving credit facility		(18.0	)		(12.0	)
Repayments of finance leases and term loans		(0.8	)		(0.4	)
Receipt of short-term borrowing		0.0			7.6
Payment for acquisition-related contingent consideration		(44.0	)		0.0
Excess tax benefit from stock-based payment arrangements		0.2			0.7
Dividend paid		(8.1	)		(7.3	)
Issue of treasury stock		0.3			1.0
Repurchase of common stock		(8.2	)		(15.4	)

Net cash used in financing activities		(50.6	)		(25.4	)
Effect of foreign currency exchange rate changes on cash		(0.3	)		(1.1	)

Net change in cash and cash equivalents		30.2			86.1
Cash and cash equivalents at beginning of period		136.9			41.6

Cash and cash equivalents at end of period	$	167.1		$	127.7

Amortization of deferred finance costs of $0.2 million (2015 – $0.6 million) are included in depreciation and amortization in the cash flow statement but in interest expense in the income statement.

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

INNOSPEC INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF EQUITY

(Unaudited)


(in millions)	Common Stock		Additional Paid-In Capital			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Loss			Non- controlling Interest		Total Equity
Balance at December 31, 2015	$	0.3	$	311.0		$	(91.8	)	$	496.4		$	(110.9	)	$	0.3	$	605.3
Net income										59.2								59.2
Dividend paid										(8.1	)							(8.1	)
Changes in cumulative translation adjustment													(0.3	)				(0.3	)
Treasury stock reissued				(0.6	)		1.0											0.4
Treasury stock repurchased							(8.2	)										(8.2	)
Excess tax benefit from stock-based payment arrangements				0.2														0.2
Stock option compensation				2.8														2.8
Amortization of prior service credit, net of tax													(0.7	)				(0.7	)
Amortization of actuarial net losses, net of tax													1.6					1.6

Balance at September 30, 2016	$	0.3	$	313.4		$	(99.0	)	$	547.5		$	(110.3	)	$	0.3	$	652.2

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

INNOSPEC INC. AND SUBSIDIARIES

NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – BASIS OF PRESENTATION

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934. Accordingly, they do not include all the information and notes necessary for a comprehensive presentation of financial position, results of operations and cash flows.

It is our opinion, however, that all adjustments (consisting of normal, recurring adjustments, unless otherwise disclosed) have been made which are necessary for the financial statements to be fairly stated. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K filed on February 17, 2016.

The results for the interim period covered by this report are not necessarily indicative of the results to be expected for the full year.

During the second quarter of 2016, we announced a change in the organization structure of the Group. As a result of these changes, information that the Company’s chief operating decision maker regularly reviews for purposes of allocating resources and assessing performance changed. Therefore, in the third quarter of 2016, the Company has reported its financial performance based on the new segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives (See Note 2 of the Notes to the Consolidated Financial Statements for further information).

When we use the terms “Innospec,” “the Corporation,” “the Company,” “Registrant,” “we,” “us” and “our,” we are referring to Innospec Inc. and its consolidated subsidiaries unless otherwise indicated or the context otherwise requires.

NOTE 2 – SEGMENT REPORTING

In the second quarter of 2016, we finalized changes to our reporting segments to reflect the development of our management structure and strategy. As a result of these changes, information that the Company’s chief operating decision maker regularly reviews for purposes of allocating resources and assessing financial performance has changed. Therefore, in the third quarter of 2016, the Company has reported its financial performance based on the four reportable segments described below.

•

Fuel Specialties, including the Polymers business previously reported in Performance Chemicals and excluding Oilfield Services business

•

Performance Chemicals, excluding the Polymers business

•

Oilfield Services, which was previously reported within Fuel Specialties

•

Octane Additives (no change)

We have recast certain prior period amounts to conform to the way we internally manage and monitor segment performance.

The Fuel Specialties, Performance Chemicals and Oilfield Services segments operate in markets where we actively seek growth opportunities although their ultimate customers are different. The Octane Additives segment is expected to decline in the near future as our one remaining refinery customer transitions to unleaded fuel.

The Company evaluates the performance of its segments based on operating income. The following table analyzes sales and other financial information by the Company’s reportable segments:


	Three Months Ended September 30						Nine Months Ended September 30
(in millions)	2016			2015			2016			2015
Net sales:
Fuel Specialties	$	114.4		$	121.3		$	367.1		$	386.6
Performance Chemicals		36.8			33.7			106.8			124.4
Oilfield Services		49.7			78.9			132.4			216.3
Octane Additives		4.6			20.3			39.3			39.0

	$	205.5		$	254.2		$	645.6		$	766.3


Gross profit:
Fuel Specialties	$	43.8		$	39.5		$	129.5		$	125.4
Performance Chemicals		12.3			9.9			34.4			33.3
Oilfield Services		20.6			32.0			52.1			82.4
Octane Additives		2.5			9.0			24.9			18.6

	$	79.2		$	90.4		$	240.9		$	259.7


Operating income:
Fuel Specialties	$	24.1		$	21.6		$	72.2		$	70.7
Performance Chemicals		4.2			3.6			13.3			13.1
Oilfield Services		0.0			7.2			(7.1	)		13.8
Octane Additives		1.9			8.0			22.5			15.9
Pension credit		1.6			0.0			5.1			0.1
Corporate costs		(15.2	)		(9.3	)		(37.8	)		(24.8	)
Adjustment to fair value of contingent consideration		2.3			8.5			6.3			31.6
Profit/(loss) on disposal of subsidiary		0.0			1.6			(1.4	)		1.6

Total operating income	$	18.9		$	41.2		$	73.1		$	122.0

The pension credit relates to the United Kingdom defined benefit pension plan which is closed to future service accrual. The charges related to our other much smaller pension arrangements in the U.S. and overseas are included in the segment and income statement captions consistent with the related employees’ costs.

The following table presents a summary of the depreciation and amortization charges incurred by the Company’s reportable segments:


	Three Months Ended September 30				Nine Months Ended September 30
(in millions)	2016		2015		2016		2015
Depreciation:
Fuel Specialties	$	0.9	$	0.7	$	2.8	$	2.3
Performance Chemicals		0.5		0.5		1.6		1.7
Oilfield Services		1.7		1.4		4.6		4.1
Octane Additives		0.1		0.1		0.4		0.3
Corporate		0.3		0.3		0.7		1.1

	$	3.5	$	3.0	$	10.1	$	9.5


Amortization:
Fuel Specialties	$	0.2	$	0.2	$	0.7	$	0.8
Performance Chemicals		1.1		1.1		3.1		3.1
Oilfield Services		2.9		3.0		8.9		8.9
Corporate		1.9		0.9		5.5		2.8

	$	6.1	$	5.2	$	18.2	$	15.6

NOTE 3 – EARNINGS PER SHARE

Basic earnings per share is based on the weighted average number of common shares outstanding during the period. Diluted earnings per share includes the effect of options that are dilutive and outstanding during the period. Per share amounts are computed as follows:


	Three Months Ended September 30				Nine Months Ended September 30
	2016		2015		2016		2015
Numerator (in millions):
Net income available to common stockholders	$	11.4	$	35.6	$	59.2	$	88.0


Denominator (in thousands):
Weighted average common shares outstanding		23,977		24,121		23,989		24,162
Dilutive effect of stock options and awards		499		490		473		498

Denominator for diluted earnings per share		24,476		24,611		24,462		24,660


Net income per share, basic:	$	0.48	$	1.48	$	2.47	$	3.64

Net income per share, diluted:	$	0.47	$	1.45	$	2.42	$	3.57

In the three and nine months ended September 30, 2016, the average number of anti-dilutive options excluded from the calculation of diluted earnings per share were 0 and 0, respectively (three and nine months ended September 30, 2015 – 21,959 and 21,959, respectively).

NOTE 4 – GOODWILL

The following table summarizes goodwill at the balance sheet dates:


(in millions)	September 30, 2016			December 31, 2015
Gross cost ⁽¹⁾	$	503.9		$	503.9
Accumulated impairment losses		(236.5	)		(236.5	)

Net book amount	$	267.4		$	267.4

⁽¹⁾	Gross cost for 2016 and 2015 is net of $298.5 million of historical accumulated amortization.

NOTE 5 – OTHER INTANGIBLE ASSETS

The following table summarizes the other intangible assets movement year on year:


	Nine Months Ended September 30
(in millions)	2016			2015
Gross cost at January 1	$	248.6		$	247.6
Capitalization of internally developed software		0.0			7.0
Exchange effect		0.0			0.1
Disposal of subsidiary		0.0			(7.7	)

Gross cost at September 30		248.6			247.0

Accumulated amortization at January 1		(79.9	)		(66.5	)
Amortization expense		(18.2	)		(15.6	)
Exchange effect		0.0			0.0
Disposal of subsidiary		0.0			7.7

Accumulated amortization at September 30		(98.1	)		(74.4	)

Net book amount at September 30	$	150.5		$	172.6

Amortization expense


	Nine Months Ended September 30
(in millions)	2016			2015
Product rights	$	(2.8	)	$	(2.8	)
Brand names		(0.9	)		(0.9	)
Technology		(2.5	)		(2.6	)
Customer relationships		(5.1	)		(5.1	)
Non-compete agreements		(0.7	)		(0.7	)
Marketing related		(0.7	)		(0.7	)
Internally developed software		(5.5	)		(2.8	)

Total	$	(18.2	)	$	(15.6	)

NOTE 6 – PENSION PLANS

The Company maintains a defined benefit pension plan (the “Plan”) covering a number of its current and former employees in the United Kingdom, although it does also have other much smaller pension arrangements in the U.S. and overseas. The Plan is closed to future service accrual but has a large number of deferred and current pensioners.


	Three Months Ended September 30						Nine Months Ended September 30
(in millions)	2016			2015			2016			2015
Plan net pension credit/(charge):
Service cost	$	(0.2	)	$	(0.5	)	$	(0.7	)	$	(1.2	)
Interest cost on projected benefit obligation		(5.0	)		(7.0	)		(16.0	)		(20.8	)
Expected return on plan assets		7.2			8.5			23.0			25.1
Amortization of prior service credit		0.2			0.3			0.8			0.9
Amortization of actuarial net losses		(0.6	)		(1.3	)		(2.0	)		(3.9	)

	$	1.6		$	0.0		$	5.1		$	0.1

The amortization of prior service credit and actuarial net losses is a reclassification out of accumulated other comprehensive loss into selling, general and administrative expenses.

The Company also maintains an unfunded defined benefit pension plan covering a number of its current and former employees in Germany (the “German plan”). The German plan is closed to new entrants and has no assets. The net pension charge for the German plan for the three and nine months ended September 30, 2016, was $0.2 million and $0.6 million, respectively (three and nine months ended September 30, 2015 - $0.1 million and $0.5 million, respectively).

NOTE 7 – INCOME TAXES

A roll-forward of unrecognized tax benefits and associated accrued interest and penalties is as follows:


(in millions)	Unrecognized Tax Benefits			Interest and Penalties			Total
Opening balance at January 1, 2016	$	3.6		$	0.3		$	3.9
Decrease for prior period tax positions		(0.6	)		(0.1	)		(0.7	)
Reductions due to lapsed statute of limitations		(0.8	)		(0.1	)		(0.9	)

Closing balance at September 30, 2016		2.2			0.1			2.3
Current		0.0			0.0			0.0

Non-current	$	2.2		$	0.1		$	2.3

All of the unrecognized tax benefits, interest and penalties, would impact our effective tax rate if recognized.

We recognize accrued interest and penalties associated with uncertain tax positions as part of income taxes in our consolidated statements of income.

The Company or one of its subsidiaries files income tax returns with the U.S. federal government, and various state and foreign jurisdictions. As previously disclosed, one of the Company’s U.S. subsidiaries is currently subject to a state tax examination in respect of 2012 through to 2014 inclusive. The Company currently anticipates that adjustments, if any, arising out of this tax audit would not result in a material change to the Company’s financial position as at September 30, 2016.

As previously disclosed, the Company’s German subsidiaries are subject to a tax audit in respect of 2010 through to 2014 inclusive. The Company currently anticipates that adjustments, if any, arising out of this tax audit would not result in a material change to the Company’s financial position as at September 30, 2016.

The Company and its U.S. subsidiaries remain open to examination by the IRS for years 2013 onwards. The Company’s subsidiaries in foreign tax jurisdictions are open to examination including France (2013 onwards), Germany (2010 onwards), Switzerland (2014 onwards) and the United Kingdom (2014 onwards).

The Company is in a position to control whether or not to repatriate foreign earnings and we currently do not expect to make a repatriation in the foreseeable future. No taxes have been provided for on the unremitted earnings of our overseas subsidiaries as any tax basis differences relating to investments in these overseas subsidiaries are considered to be permanent in duration. The amount of unremitted earnings at December 31, 2015 was approximately $775 million. If these earnings are remitted, additional taxes could result after offsetting foreign income taxes paid although the calculation of the additional taxes is not practicable to compute at this time.

NOTE 8 – LONG-TERM DEBT

Long-term debt consists of the following:


(in millions)	September 30, 2016		December 31, 2015
Revolving credit facility	$	143.0	$	133.0

NOTE 9 – PLANT CLOSURE PROVISIONS

The liability for estimated closure costs of Innospec’s manufacturing facilities includes costs for decontamination and environmental remediation activities (“remediation”). The principal site giving rise to remediation liabilities is the manufacturing site at Ellesmere Port in the United Kingdom. There are also remediation liabilities on a much smaller scale in respect of our other manufacturing sites in the U.S. and Europe.

Movements in the provisions are summarized as follows:


	Nine Months Ended September 30
(in millions)	2016			2015
Total at January 1	$	37.7		$	34.1
Charge for the period		3.5			3.1
Utilized in the period		(2.1	)		(1.7	)
Disposal in the period		0.0			(0.3	)
Exchange effect		0.1			(0.2	)

Total at September 30		39.2			35.0
Due within one year		(5.0	)		(3.8	)

Due after one year	$	34.2		$	31.2

Amounts due within one year refer to provisions where expenditure is expected to arise within one year of the balance sheet date.

NOTE 10 – FAIR VALUE MEASUREMENTS

The following table presents the carrying amount and fair values of the Company’s assets and liabilities measured on a recurring basis:


	September 30, 2016				December 31, 2015
(in millions)	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Assets
Non-derivatives:
Cash and cash equivalents	$	167.1	$	167.1	$	136.9	$	136.9
Short-term investments		0.0		0.0		4.8		4.8

Liabilities
Non-derivatives:
Long-term debt (including current portion)	$	143.0	$	143.0	$	133.0	$	133.0
Finance leases (including current portion)		4.5		4.5		3.1		3.1
Derivatives (Level 1 measurement):
Other non-current liabilities:
Foreign currency forward exchange contracts		0.6		0.6		0.3		0.3
Non-financial liabilities (Level 3 measurement):
Acquisition-related contingent consideration		4.3		4.3		54.6		54.6
Stock equivalent units		9.1		9.1		7.8		7.8

The following methods and assumptions were used to estimate the fair values of financial instruments:

Cash and cash equivalents and short-term investments: The carrying amount approximates fair value because of the short-term maturities of such instruments.

Long-term debt and finance leases: Long-term debt principally comprises the revolving credit facility. Finance leases relate to certain fixed assets in our Oilfield Services businesses. The carrying amount of long-term debt and finance leases approximates the fair value.

Derivatives: The fair value of derivatives relating to foreign currency forward exchange contracts are derived from current settlement prices and comparable contracts using current assumptions. Foreign currency forward exchange contracts primarily relate to contracts entered into to hedge future known transactions or hedge balance sheet net cash positions. The movements in the carrying amounts and fair values of these contracts are largely due to changes in exchange rates against the U.S. dollar.

Acquisition-related contingent consideration: Contingent consideration payable in cash is discounted to its estimated fair value at each balance sheet date. Where contingent consideration is dependent upon pre-determined financial targets, an estimate of the fair value of the likely consideration payable is made at each balance sheet date. The carrying value of the contingent consideration at the balance

sheet dates is based on the estimated EBITDA (earnings before interest, taxes, depreciation and amortization) and free cash flow generated by Independence Oilfield Chemicals LLC (“Independence”) through the period to October 31, 2016. The contingent consideration payable in relation to the acquisition of Independence is based on management’s latest forecasts of the business and on the current trading performance. The results of the Independence business are particularly sensitive to the level of exploration, development and production activity of our customers in the oil and gas sector, which is directly affected by trends in oil prices.

Stock equivalent units: The fair values of stock equivalent units are calculated at each balance sheet date using either the Black-Scholes or Monte Carlo method depending on the terms of each grant.

NOTE 11 – DERIVATIVE INSTRUMENTS AND RISK MANAGEMENT

The Company enters into various foreign currency forward exchange contracts to minimize currency exchange rate exposure from expected future cash flows. As at September 30, 2016 the contracts have maturity dates of up to twelve months at the date of inception. These foreign currency forward exchange contracts have not been designated as hedging instruments, and their impact on the income statement for the first nine months of 2016 was a gain of $3.2 million.

NOTE 12 – COMMITMENTS AND CONTINGENCIES

Legal matters

While we are involved from time to time in claims and legal proceedings that result from, and are incidental to, the conduct of our business including business and commercial litigation, employee and product liability claims, there are no material pending legal proceedings to which the Company or any of its subsidiaries is a party, or of which any of their property is subject. It is possible, however, that an adverse resolution of an unexpectedly large number of such individual claims or proceedings could in the aggregate have a material adverse effect on the results of operations for a particular year or quarter.

Guarantees

The Company and certain of the Company’s consolidated subsidiaries are contingently liable for certain obligations of affiliated companies primarily in the form of guarantees of debt and performance under contracts entered into as a normal business practice. This includes guarantees of non-U.S. excise taxes and customs duties. As at September 30, 2016, such guarantees which are not recognized as liabilities in the consolidated financial statements amounted to $3.7 million.

Under the terms of the guarantee arrangements, generally the Company would be required to perform should the affiliated company fail to fulfil its obligations under the arrangements. In some cases, the guarantee arrangements have recourse provisions that would enable the Company to recover any payments made under the terms of the guarantees from securities held of the guaranteed parties’ assets.

The Company and its affiliates have numerous long-term sales and purchase commitments in their various business activities, which are expected to be fulfilled with no adverse consequences material to the Company.

NOTE 13 – STOCK-BASED COMPENSATION PLANS

The Company grants stock options and stock equivalent units (“SEUs”) from time to time as a long-term performance incentive. In certain cases the grants are subject to performance conditions such as the Company’s stock price. Where performance conditions apply the Monte Carlo simulation model is used to determine the fair values. Otherwise the Black-Scholes model is used to determine the fair values.

Stock option plans

The following table summarizes the transactions of the Company’s stock option plans for the nine months ended September 30, 2016:


	Number of Options			Weighted Average Exercise Price		Weighted Average Grant-Date Fair Value
Outstanding at December 31, 2015		667,439		$	19.87	$	20.19
Granted - at discount		67,546		$	0.00	$	38.13
- at market value		24,794		$	44.34	$	9.17
Exercised		(58,125	)	$	5.42	$	28.50
Forfeited		(24,273	)	$	21.15	$	21.12

Outstanding at September 30, 2016		677,381		$	19.97	$	20.83

At September 30, 2016, there were 112,604 stock options that were exercisable, of which 30,712 had performance conditions attached.

The stock option compensation cost for the first nine months of 2016 was $2.8 million (2015 – $2.7 million). The total intrinsic value of options exercised in the first nine months of 2016 was $1.8 million (2015 – $2.1 million).

The total compensation cost related to non-vested stock options not yet recognized at September 30, 2016 was $4.3 million and this cost is expected to be recognized over the weighted-average period of 2.08 years.

Stock equivalent units

The following table summarizes the transactions of the Company’s SEUs for the nine months ended September 30, 2016:


	Number of SEUs			Weighted Average Exercise Price		Weighted Average Grant-Date Fair Value
Outstanding at December 31, 2015		279,750		$	3.79	$	31.72
Granted - at discount		70,153		$	0.00	$	36.56
- at market value		7,316		$	44.18	$	9.11
Exercised		(49,623	)	$	1.74	$	27.79
Forfeited		(8,980	)	$	4.41	$	30.73

Outstanding at September 30, 2016		298,616		$	4.21	$	32.99

At September 30, 2016 there were 59,765 SEUs that are exercisable, of which 51,163 had performance conditions attached.

The charges for SEUs are spread over the life of the award subject to a revaluation to fair value each quarter. The revaluation may result in a charge or a credit to the income statement in the quarter dependent upon our share price and other performance criteria.

The SEU compensation cost for the first nine months of 2016 was $3.7 million (2015 - $2.4 million). The total intrinsic value of SEUs exercised in the first nine months of 2016 was $1.5 million (2015 – $2.2 million).

The weighted-average remaining vesting period of non-vested SEUs is 1.61 years.

Additional exceptional long-term incentive plan

A maximum of $3.0 million of our cash-settled long-term incentives is accounted for as share-based compensation and the fair value is calculated on a quarterly basis using a Monte Carlo model. The fair values at each of the balance sheet dates are summarized as follows:


(in millions)	2016		2015
Balance at January 1	$	1.0	$	0.1
Compensation charge for the period		0.6		0.4

Balance at September 30	$	1.6	$	0.5

The following assumptions were used in the Monte Carlo model at September 30:


	2016			2015
Dividend yield		1.05	%		1.25	%
Volatility of Innospec’s share price		25.55	%		24.47	%
Risk free interest rate		0.88	%		0.92	%

NOTE 14 – RECLASSIFICATIONS OUT OF ACCUMULATED OTHER COMPREHENSIVE LOSS

Reclassifications out of accumulated other comprehensive loss for the first nine months of 2016 were:


(in millions)	Amount Reclassified from AOCL			Affected Line Item in the Statement where Net Income is Presented
Details about AOCL Components	Amount Reclassified from AOCL
Defined benefit pension plan items:
Amortization of prior service credit	$	(0.8	)	See ⁽¹⁾ below
Amortization of actuarial net losses		2.0		See ⁽¹⁾ below

		1.2		Total before tax
		(0.3	)	Income tax expense

Total reclassifications	$	0.9		Net of tax

⁽¹⁾	These items are included in the computation of net periodic pension cost. See Note 6 of the Notes to the Consolidated Financial Statements for additional information.

Changes in accumulated other comprehensive loss for the first nine months of 2016, net of tax, were:


(in millions)	Defined Benefit Pension Plan Items			Cumulative Translation Adjustments			Total
Balance at December 31, 2015	$	(50.9	)	$	(60.0	)	$	(110.9	)

Other comprehensive income before reclassifications		0.0			(0.3	)		(0.3	)
Amounts reclassified from AOCL		0.9			0.0			0.9

Total other comprehensive income		0.9			(0.3	)		0.6

Balance at September 30, 2016	$	(50.0	)	$	(60.3	)	$	(110.3	)

NOTE 15 – RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In May 2014, the FASB issued Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers ASC Topic 606, which amends the existing accounting standards for revenue recognition. ASU 2014-09 is based on principles that govern the recognition of revenue at an amount an entity expects to be entitled when products are transferred to customers. The original effective date for ASU 2014-09 was for annual and interim periods within those years beginning after December 15, 2016. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers – Deferral of the Effective Date, which defers the effective date of ASU 2014-09 for one year and permits early adoption as early as the original effective date of ASU 2014-09. The new revenue standard may be applied retrospectively to each prior period presented or retrospectively with the cumulative effect recognized as of the date of adoption. The Company has been evaluating the potential timing and impact of adopting the new revenue standard on its consolidated financial statements and has not yet determined the effect of the standard on its ongoing financial reporting.

In February 2016, the FASB issued Accounting Standards Update (ASU) 2016-02, Revision to Lease Accounting, which amends ASC Topic 842, Leases. The ASU requires lessees to recognize a right-of-use asset and a lease liability for virtually all of their leases (other than leases that meet the definition of a short-term lease). The new standard is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition, and provides for certain practical expedients. Transition will require application of the new guidance at the beginning of the earliest comparative period presented. The Company has not yet determined the effect of the standard on its ongoing financial reporting.

In June 2016, the FASB issued a new standard Accounting Standard Update 2016-13 to replace the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to develop credit loss estimates. For trade and other receivables, loans, and other financial instruments, we will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses. The new standard is effective for fiscal periods beginning after December 15, 2019. Early adoption is permitted. The Company has not yet determined the effect of the standard on its ongoing financial reporting.

NOTE 16 – RELATED PARTY TRANSACTIONS

Mr. Robert I. Paller has been a non-executive director of the Company since November 1, 2009. The Company has retained and continues to retain Smith, Gambrell & Russell, LLP (“SGR”), a law firm with which Mr. Paller holds a position. In the first nine months of 2016 the Company incurred fees from SGR of $0.4 million (2015 – $0.3 million). As at September 30, 2016, the amount due to SGR from the Company was $0.1 million (December 31, 2015 - $0.1 million).

NOTE 17 – SUBSEQUENT EVENT

On July 29, 2016 Innospec International Ltd., a wholly–owned subsidiary of Innospec Inc. entered into an Exclusivity and Put Option Agreement with Huntsman Investments B.V. (“the Seller”). The Put Option Agreement set forth the terms of a commitment to acquire the European Personal Care and Home Care business of the Seller.

On October 25, 2016, pursuant to the terms of the Put Option Agreement, the Company entered into a Share and Asset Purchase Agreement (the “SAPA”). The aggregate purchase price to be paid under the SAPA is approximately $200 million subject to adjustments for certain working capital items, inventory and certain adjustments related to employee matters.

The Proposed Transaction is expected to close in the Fourth quarter of 2016 subject to customary closing conditions.

Item 2

Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Three and Nine Months Ended September 30, 2016

This discussion should be read in conjunction with our unaudited interim consolidated financial statements and the notes thereto.

CRITICAL ACCOUNTING ESTIMATES

The policies and estimates that the Company considers the most critical in terms of complexity and subjectivity of assessment are those related to business combinations, contingencies, environmental liabilities, pensions, deferred tax and uncertain income tax positions, goodwill, property, plant and equipment and other intangible assets (net of amortization). These policies have been discussed in the Company’s 2015 Annual Report on Form 10-K.

RESULTS OF OPERATIONS

In the second quarter of 2016, we finalized changes to our reporting segments to reflect the development of our management structure and strategy. As a result of these changes, information that the Company’s chief operating decision maker regularly reviews for purposes of allocating resources and assessing financial performance has changed. Therefore, in the third quarter of 2016, the Company reported its financial performance based on the four reportable segments described below.

•

Fuel Specialties, including the Polymers business previously reported in Performance Chemicals and excluding Oilfield Services business

•

Performance Chemicals, excluding the Polymers business

•

Oilfield Services, which was previously reported within Fuel Specialties

•

Octane Additives (no change)

We have recast certain prior period amounts to conform to the way we internally manage and monitor segment performance.

The following table provides operating income by reporting segment:


	Three Months Ended September 30						Nine Months Ended September 30
(in millions)	2016			2015			2016			2015
Net sales:
Fuel Specialties	$	114.4		$	121.3		$	367.1		$	386.6
Performance Chemicals		36.8			33.7			106.8			124.4
Oilfield Services		49.7			78.9			132.4			216.3
Octane Additives		4.6			20.3			39.3			39.0

	$	205.5		$	254.2		$	645.6		$	766.3

Gross profit:
Fuel Specialties	$	43.8		$	39.5		$	129.5		$	125.4
Performance Chemicals		12.3			9.9			34.4			33.3
Oilfield Services		20.6			32.0			52.1			82.4
Octane Additives		2.5			9.0			24.9			18.6

	$	79.2		$	90.4		$	240.9		$	259.7

Operating income:
Fuel Specialties	$	24.1		$	21.6		$	72.2		$	70.7
Performance Chemicals		4.2			3.6			13.3			13.1
Oilfield Services		0.0			7.2			(7.1	)		13.8
Octane Additives		1.9			8.0			22.5			15.9
Pension credit		1.6			0.0			5.1			0.1
Corporate costs		(15.2	)		(9.3	)		(37.8	)		(24.8	)
Adjustment to fair value of contingent consideration		2.3			8.5			6.3			31.6
Profit/(loss) on disposal of subsidiary		0.0			1.6			(1.4	)		1.6

Total operating income	$	18.9		$	41.2		$	73.1		$	122.0


	Three Months Ended September 30
(in millions, except ratios)	2016			2015			Change
Net sales:
Fuel Specialties	$	114.4		$	121.3		$	(6.9	)	-6	%
Performance Chemicals		36.8			33.7			3.1		+9	%
Oilfield Services		49.7			78.9			(29.2	)	-37	%
Octane Additives		4.6			20.3			(15.7	)	-77	%

	$	205.5		$	254.2		$	(48.7	)	-19	%

Gross profit:
Fuel Specialties	$	43.8		$	39.5		$	4.3		+11	%
Performance Chemicals		12.3			9.9			2.4		+24	%
Oilfield Services		20.6			32.0			(11.4	)	-36	%
Octane Additives		2.5			9.0			(6.5	)	-72	%

	$	79.2		$	90.4		$	(11.2	)	-12	%

Gross margin (%):
Fuel Specialties		38.3			32.6			+5.7
Performance Chemicals		33.4			29.4			+4.0
Oilfield Services		41.4			40.6			+0.8
Octane Additives		54.3			44.3			+10.0
Aggregate		38.5			35.6			+2.9

Operating expenses:
Fuel Specialties	$	(19.7	)	$	(17.9	)	$	(1.8	)	+10	%
Performance Chemicals		(8.1	)		(6.3	)		(1.8	)	+29	%
Oilfield Services		(20.6	)		(24.8	)		4.2		-17	%
Octane Additives		(0.6	)		(1.0	)		0.4		-40	%
Pension credit		1.6			0.0			1.6		n/a
Corporate costs		(15.2	)		(9.3	)		(5.9	)	+63	%
Adjustment to fair value of contingent consideration		2.3			8.5			(6.2	)	-73	%
Profit on disposal of subsidiary		0.0			1.6			(1.6	)	n/a

	$	(60.3	)	$	(49.2	)	$	(11.1	)	+23	%

Fuel Specialties

Net sales: the table below details the components which comprise the year on year change in net sales spread across the markets in which we operate:


	Three Months Ended September 30, 2016
Change (%)	Americas		EMEA		ASPAC		AvTel		Total
Volume		-11		+10		+17		-27		0
Price and product mix		-2		-10		-3		-5		-6
Exchange rates		0		-1		0		0		0

		-13		-1		+14		-32		-6

Volumes in the Americas were lower compared to the prior year due to a change in refinery crude slates. EMEA and ASPAC volumes increased from the prior year driven by increased demand for higher volume lower margin products. AvTel volumes were lower than the prior year with an adverse price and product mix driven by the phasing of demand from customers. EMEA was adversely impacted by exchange rate movements year over year, driven by a strengthening of the U.S. dollar against the British pound sterling and European Union euros.

Gross margin: the year on year increase of 5.7 percentage points was primarily achieved from reduced sales of lower margin products in the Americas together with the positive effect of weaker exchange rates versus the U.S. dollar on our cost base in EMEA and ASPAC.

Operating expenses: the year on year increase of $1.8 million was primarily due to higher share-based compensation accruals driven by the rise in the Innospec share price in the quarter relative to the prior year, together with increased provisions against doubtful debts.

Performance Chemicals

Net sales: the table below details the components which comprise the year on year change in net sales spread across the markets in which we operate:

Three Months Ended September 30, 2016

Change (%)

Americas

EMEA

ASPAC

Total

Volume

+35

+34

+14

Price and product mix

-13

+11

-1

Exchange rates

-9

-18

-4

+13

+27

Volumes in all our markets were higher, primarily due to increased Personal Care volumes. EMEA experienced pricing pressure in Personal Care which adversely affected the price and product mix. ASPAC price and product mix benefited from favorable pricing in Personal Care. A weakening of the European Union euro and the British pound sterling against the U.S. dollar resulted in an adverse exchange rate variance for EMEA and ASPAC.

Gross margin: the year on year increase of 4.0 percentage points, was due to a greater proportion of sales from our higher margin Personal Care business and the positive effect of weaker exchange rates versus the U.S. dollar on our cost base in EMEA and ASPAC.

Operating expenses: the year on year increase of 29 percent or $1.8 million was driven by a $1.0 million commercial legal settlement with a distributor, together with higher share-based compensation accruals driven by the rise in the Innospec share price in the quarter relative to the prior year and higher performance related compensation.

Oilfield Services

Net sales: the year on year decrease of $29.2 million was primarily due to a reduction in customer activity especially in well completion, following the decline in oil prices. Overall volumes declined by 30 percent together with an adverse price and product mix of 7 percent.

Gross margin: the year on year increase of 0.8 percentage points was primarily due to a favorable sales mix driven by a higher proportion of sales from our higher margin production business.

Operating expenses: the year on year decrease of $4.2 million was driven by our cost reduction programs.

Octane Additives

Net sales: the year on year decrease of $15.7 million was due to the timing of demand with our one remaining refinery customer.

Gross margin: the year on year increase of 10.0 percentage points was primarily due to higher volumes of production in the quarter generating favorable manufacturing variances, together with the benefit of a weaker British pound sterling against the U.S. dollar for our Ellesmere Port cost base.

Operating expenses: the year on year decrease of $0.4 million was due to the timing of maintenance expenditure and the benefit of a weaker British pound sterling against the U.S. dollar for our Ellesmere Port cost base.

Other Income Statement Captions

Pension credit: is non-cash, and was a $1.6 million net credit in 2016 compared to $0.0 million in 2015 primarily driven by lower interest cost on the projected benefit obligation.

Corporate costs: the year on year increase of $5.9 million, related to $1.4 million higher amortization and other costs related to the EMEA and ASPAC deployment of our group wide ERP system; $1.7 million acquisition-related legal and professional fees in the current quarter; $2.1 million related to higher personnel-related compensation, including higher accruals for share-based compensation driven by the rise in the Innospec share price in the quarter; and $0.7 million higher legal, professional and other expenses.

Adjustment to fair value of contingent consideration: the credit of $2.3 million relates to an adjustment to the carrying value of our liability for contingent consideration of $2.4 million, partly offset by the accretion charge of $0.1 million, both in relation to our Independence acquisition. The carrying value of the contingent consideration is based on the estimated EBITDA and free cash flow generated by the Independence business through the period to October 31, 2016. The contingent consideration payable is based on management’s latest forecast of the business and on the current trading performance. The results of the business are particularly sensitive to the level of exploration, development and production activity of our customers in the oil and gas sector, which is directly affected by trends in oil prices.

Profit on disposal of subsidiary: In 2015, the disposal of our Aroma Chemicals business generated a profit on disposal of $1.6 million in the third quarter.

Other net income/(expense): other net expense of $5.0 million primarily related to net losses of $5.2 million on translation of assets and liabilities denominated in non-functional currencies in our European businesses, offset by gains of $0.2 million on foreign currency forward exchange contracts. In 2015, other net income of $1.2 million primarily related to net gains of $1.2 million on foreign currency forward exchange contracts.

Interest expense, net: was $0.7 million in 2016 and $1.0 million in 2015, with the reduction due to the lower borrowing costs within our new credit facility.

Income taxes: the effective tax rate was 13.6% and 14.0% in the third quarter of 2016 and 2015, respectively. The adjusted effective tax rate, once adjusted for changes to the fair value contingent consideration and the adjustment of income tax provisions, was 19.4% in the third quarter of 2016 compared with 13.9% in the third quarter of 2015. The 5.5% increase in the adjusted effective tax rate was primarily due to the third quarter of 2016 benefiting, to a lesser extent, from the positive impact of taxable profits in different geographical locations as compared to the third quarter of 2015 and the impact of a 1% prospective reduction in the United Kingdom’s corporation tax rate in the third quarter of 2016 on the measurement of existing deferred tax balances. The Company believes that this adjusted effective tax rate, a non-GAAP financial measure, provides useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, management uses this non-GAAP financial measure internally to evaluate the performance of the Company’s operations and for planning and forecasting in subsequent periods.


	Three Months Ended September 30
(in millions)	2016			2015
Income before income taxes	$	13.2		$	41.4
Adjustment to fair value of contingent consideration		(2.4	)		(11.1	)

	$	10.8		$	30.3


Income taxes	$	1.8		$	5.8
Tax on adjustment to fair value of contingent consideration		(0.9	)		(4.2	)
Adjustment of income tax positions		1.2			2.6

	$	2.1		$	4.2


GAAP effective tax rate		13.6	%		14.0	%
Adjusted effective tax rate		19.4	%		13.9	%


	Nine Months Ended September 30
(in millions, except ratios)	2016			2015			Change
Net sales:
Fuel Specialties	$	367.1		$	386.6		$	(19.5	)	-5	%
Performance Chemicals		106.8			124.4			(17.6	)	-14	%
Oilfield Services		132.4			216.3			(83.9	)	-39	%
Octane Additives		39.3			39.0			0.3		+1	%

	$	645.6		$	766.3		$	(120.7	)	-16	%

Gross profit:
Fuel Specialties	$	129.5		$	125.4		$	4.1		+3	%
Performance Chemicals		34.4			33.3			1.1		+3	%
Oilfield Services		52.1			82.4			(30.3	)	-37	%
Octane Additives		24.9			18.6			6.3		+34	%

	$	240.9		$	259.7		$	(18.8	)	-7	%

Gross margin (%):
Fuel Specialties		35.3			32.4			+2.9
Performance Chemicals		32.2			26.8			+5.4
Oilfield Services		39.4			38.1			+1.3
Octane Additives		63.4			47.7			+15.7
Aggregate		37.3			33.9			+3.4

Operating expenses:
Fuel Specialties	$	(57.3	)	$	(54.7	)	$	(2.6	)	+5	%
Performance Chemicals		(21.1	)		(20.2	)		(0.9	)	+4	%
Oilfield Services		(59.2	)		(68.6	)		9.4		-14	%
Octane Additives		(2.4	)		(2.7	)		0.3		-11	%
Pension credit		5.1			0.1			5.0		n/a
Corporate costs		(37.8	)		(24.8	)		(13.0	)	-52	%
Adjustment to fair value of contingent consideration		6.3			31.6			(25.3	)	-80	%
(Loss)/profit on disposal of subsidiary		(1.4	)		1.6			(3.0	)	n/a

	$	(167.8	)	$	(137.7	)	$	(30.1	)	+22	%

Fuel Specialties

Net sales: the table below details the components which comprise the year on year change in net sales spread across the markets in which we operate:


	Nine Months Ended September 30, 2016
Change (%)	Americas		EMEA		ASPAC		AvTel		Total
Volume		-18		+12		+8		+7		0
Price and product mix		-1		-9		-3		-3		-4
Exchange rates		0		-1		0		0		-1

		-19		+2		+5		+4		-5

Volumes in the Americas were lower than the prior year due to softer fuel demand, a warmer winter and a change in the refinery crude slates. EMEA and ASPAC volumes increased from the prior year driven by increased demand for high volume low margin products. Price and product mix in EMEA and ASPAC was adversely impacted by higher demand for lower margin products together with some pricing pressures. AvTel volumes were higher than the prior year with an adverse price and product mix driven by the phasing of demand from customers. EMEA was adversely impacted by exchange rate movements year over year, driven by a weakening of the European Union euro and the British pound sterling against the U.S. dollar.

Gross margin: the year on year increase of 2.9 percentage points was primarily achieved from reduced sales of lower margin products in the Americas, together with the positive effect of weaker exchange rates versus the U.S. dollar on our cost base in EMEA and ASPAC and the higher margin contribution from additional AvTel volumes.

Operating expenses: the year on year increase of $2.6 million, was primarily driven by increased share-based compensation accruals due to the rise in the Innospec share price in the year together with increased provisions against doubtful debts.

Performance Chemicals

Net sales: the table below details the components which comprise the year on year change in net sales spread across the markets in which we operate:


	Nine Months Ended September 30, 2016
Change (%)	Americas		EMEA		ASPAC		Aroma Chemicals		Total
Volume		+8		+24		+17		0		+12
Disposals		0		0		0		-20		-20
Price and product mix		-2		-13		+4		0		-4
Exchange rates		0		-2		-3		0		-1

		+6		+9		+18		-20		-13

Volumes were higher in all our regions, driven by increased Personal Care volumes. Americas and EMEA experienced pricing pressures in Personal Care which adversely affected the price and product mix. ASPAC benefited from favorable pricing in Personal Care. A weakening of the European Union euro and British pound sterling against the U.S. dollar resulted in an adverse exchange rate variance for EMEA and ASPAC.

Gross margin: the year on year increase of 5.4 percentage points was primarily driven by a greater proportion of sales from our higher margin Personal Care business following the disposal of our lower margin Aroma Chemicals business in the prior year, together with the positive effect of weaker exchange rates versus the U.S. dollar on our cost base in EMEA and ASPAC.

Operating expenses: The year on year increase of $0.9 million is primarily due to a $1.0 million commercial legal settlement with a distributor; higher share-based compensation accruals driven by the rise in the Innospec share price in the quarter relative to the prior year; higher performance related compensation; partly offset by a $0.6 million reduction due to the disposal of our Aroma Chemicals business during the prior year.

Oilfield Services

Net sales: the year on year decrease of $83.9 million was primarily due to a reduction in customer activity especially in well completion, following the decline in oil prices. Overall volumes declined by 28 percent together with an adverse price and product mix of 11 percent.

Gross margin: the year on year increase of 1.3 percentage points was primarily due to a favorable sales mix driven by a higher proportion of sales from our higher margin production business.

Operating expenses: the year on year decrease of $9.4 million was driven by our cost reduction programs.

Octane Additives

Net sales: have increased by $0.3 million compared to the prior year.

Gross margin: the year on year increase of 15.7 percentage points was primarily due to higher volumes of production in the first nine months of 2016 generating favorable manufacturing variances together with the benefit of a weaker British pound sterling against the U.S. dollar for our Ellesmere Port cost base.

Operating expenses: the year on year decrease of $0.3 million was due to the continuing efficient management of the cost base and the benefit of a weaker British pound sterling against the U.S. dollar for our Ellesmere Port cost base.

Other Income Statement Captions

Pension credit: is non-cash, and was a $5.1 million net credit in 2016 compared to a $0.1 million net credit in 2015 primarily driven by lower interest cost on the projected benefit obligation.

Corporate costs: the year on year increase of $13.0 million, related to $4.0 million higher amortization and other costs related to the EMEA and ASPAC deployment of our group wide ERP system; $2.7 million acquisition-related legal and professional fees; $4.6 million higher legal, professional and other expenses primarily due to the recovery of legal fees in the prior year and a $1.7 million increase related to higher personnel-related compensation, including higher accruals for share-based compensation driven by the rise in the Innospec share price in the year.

Adjustment to fair value of contingent consideration: the credit of $6.3 million relates to an adjustment to the carrying value of our liability for contingent consideration of $7.1 million, partly offset by the accretion charge of $0.8 million, both in relation to our Independence acquisition. The carrying value of the contingent consideration is based on the estimated EBITDA and free cash flow generated by the Independence business through the period to October 31, 2016. The contingent consideration payable is based on management’s latest forecast of the business and on the current trading performance. The results of the business are particularly sensitive to the level of exploration, development and production activity of our customers in the oil and gas sector, this is directly affected by trends in oil prices.

Profit on disposal of subsidiary: The disposal of our Aroma Chemicals business generated a loss on disposal in 2016 compared to a profit on disposal of $1.6 million in the prior year. The loss on disposal in 2016 related to the finalization of the assets and liabilities disposed.

Other net income/(expense): other net income of $3.2 million primarily related to net gains on foreign currency forward contracts. In 2015, other net expense of $2.0 million primarily related to losses of $2.1 million on translation of net assets denominated in non-functional currencies in our European businesses, partly offset by gains of $0.1 million on foreign currency forward contracts.

Interest expense, net: was $2.2 million in 2016 and $2.9 million in 2015, with the reduction due to the lower borrowing costs within our new credit facility.

Income taxes: the effective tax rate was 20.1% and 24.9% in the first nine months of 2016 and 2015, respectively. The adjusted effective tax rate, once adjusted for changes to the fair value contingent consideration and the adjustment of income tax provisions, was 20.2% in the first nine months of 2016 compared with 21.2% in the first nine months of 2015. The 1.0% decrease in the adjusted effective tax rate was primarily due to the first nine months of 2016 benefiting, to a greater extent, from the positive impact of taxable profits in different geographical locations as compared to the first nine months of 2015. The Company believes that this adjusted effective tax rate, a non-GAAP financial measure, provides useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, management uses this non-GAAP financial measure internally to evaluate the performance of the Company’s operations and for planning and forecasting in subsequent periods.


	Nine Months Ended September 30
(in millions)	2016			2015
Income before income taxes	$	74.1		$	117.1
Adjustment to fair value of contingent consideration		(7.1	)		(41.0	)
Loss on disposal of subsidiary		1.4			0.0

	$	68.4		$	76.1


Income taxes	$	14.9		$	29.1
Adjustment of income tax positions		1.6			2.6
Tax on adjustment to fair value of contingent consideration		(2.7	)		(15.6	)

	$	13.8		$	16.1


GAAP effective tax rate		20.1	%		24.9	%
Adjusted effective tax rate		20.2	%		21.2	%

LIQUIDITY AND FINANCIAL CONDITION

Working Capital

The Company believes that adjusted working capital, a non-GAAP financial measure, (defined by the Company as trade and other accounts receivable, inventories, prepaid expenses, accounts payable and accrued liabilities rather than total current assets less total current liabilities) provides useful information to investors in evaluating the Company’s underlying performance and identifying operating trends. Management uses this non-GAAP financial measure internally to allocate resources and evaluate the performance of the Company’s operations. Items excluded from working capital in the adjusted working capital calculation are listed in the table below and represent factors which do not fluctuate in line with the day to day working capital needs of the business.


(in millions)	September 30, 2016			December 31, 2015
Total current assets	$	479.2		$	458.7
Total current liabilities		(159.0	)		(206.1	)

Working capital		320.2			252.6
Less cash and cash equivalents		(167.1	)		(136.9	)
Less short-term investments		0.0			(4.8	)
Less current portion of deferred tax assets		(8.6	)		(8.8	)
Less prepaid income taxes		(7.0	)		(3.0	)
Less other current assets		0.0			(1.8	)
Add back current portion of accrued income taxes		11.8			7.9
Add back current portion of finance leases		1.6			0.7
Add back current portion of plant closure provisions		5.0			6.4
Add back current portion of acquisition-related contingent consideration		4.3			54.6
Add back current portion of deferred income		0.2			0.2

Adjusted working capital	$	160.4		$	167.1

In the first nine months of 2016 our adjusted working capital decreased by $6.7 million primarily driven by the collection of accounts receivable following higher sales in the fourth quarter of 2015.

We had an $11.9 million decrease in trade and other accounts receivable in 2016 primarily in our Fuel Specialties segment. Days’ sales outstanding in our Fuel Specialties segment increased from 47 days to 52 days; increased from 43 days to 48 days in our Performance Chemicals segment; and decreased from 44 days to 39 in our Oilfield Services segment.

We had a $1.9 million increase in inventories in 2016, which is primarily related to increased inventory from the higher production volumes in our Octane Additives segment partly offset by lower inventories in our Oilfield Services segment to align with lower demand from customers. Days’ sales in inventory in our Fuel Specialties segment increased from 96 days to 121 days; increased in our Performance Chemicals segment from 83 days to 90 days; and decreased from 82 to 71 days in our Oilfield Services segment.

Prepaid expenses increased by $3.1 million in the first nine months of 2016 from $6.1 million to $9.2 million due to the phasing of invoicing of certain costs.

We had a $0.2 million decrease in accounts payable and accrued liabilities in 2016. Creditor days in our Fuel Specialties segment increased from 26 days to 38 days; in our Performance Chemicals segment increased from 31 days to 32 days; and increased from 32 days to 43 days in our Oilfield Services segment.

Operating Cash Flows

We have generated cash from operating activities of $86.8 million in the first nine months of 2016 compared to $90.6 million in the first nine months of 2015 primarily due to lower operational cash flows in the period, partly offset by lower cash contributions to defined benefit pension plans.

Cash

At September 30, 2016 and December 31, 2015 we had cash and cash equivalents of $167.1 million and $136.9 million, respectively, of which $158.7 million and $118.8 million, respectively, were held by non-U.S. subsidiaries principally in the United Kingdom. The Company is in a position to control whether or not to repatriate foreign earnings. We currently do not expect to make a repatriation in the foreseeable future and hence have not provided for future income taxes on the cash held by overseas subsidiaries. If circumstances were to change that would cause these earnings to be repatriated, an additional U.S. tax liability could be incurred, and we continue to monitor this position.

Short-term investments

At September 30, 2016 and December 31, 2015, the Company had no short-term investments and $4.8 million, respectively.

Debt

At September 30, 2016, the Company had $143.0 million of debt outstanding under the revolving credit facility and $4.5 million of obligations under finance leases relating to certain fixed assets within our Oilfield Services segment.

The Company has a revolving credit facility that provides for borrowing of up to $200.0 million through November 2020 and may be drawn down in full in the U.S..

Item 3

Quantitative and Qualitative Disclosures about Market Risk

The Company uses floating rate debt to finance its global operations. The Company is subject to business risks inherent in non-U.S. activities, including political and economic uncertainty, import and export limitations, and market risk related to changes in interest rates and foreign currency exchange rates. The political and economic risks are mitigated by the stability of the major countries in which the Company’s largest operations are located. Credit limits, ongoing credit evaluation and account monitoring procedures are used to minimize bad debt risk. Collateral is not generally required.

From time to time, the Company uses derivatives, including interest rate swaps, commodity swaps and foreign currency forward exchange contracts, in the normal course of business to manage market risks. The derivatives used in hedging activities are considered risk management tools and are not used for trading purposes. In addition, the Company enters into derivative instruments with a diversified group of major financial institutions in order to manage the exposure to non-performance of such instruments. The Company’s objective in managing the exposure to changes in interest rates is to limit the impact of such changes on earnings and cash flows and to lower overall borrowing costs. The Company’s objective in managing the exposure to changes in foreign currency exchange rates is to reduce volatility on earnings and cash flows associated with such changes.

The Company offers fixed prices for some long-term sales contracts. As manufacturing and raw material costs are subject to variability the Company, from time to time, uses commodity swaps to hedge the cost of some raw materials thus reducing volatility on earnings and cash flows. The derivatives are considered risk management tools and are not used for trading purposes. The Company’s objective is to manage its exposure to fluctuating costs of raw materials.

The Company’s exposure to market risk has been discussed in the Company’s 2015 Annual Report on Form 10-K and there have been no significant changes since that time other than as discussed in item 1A below.

Item 4

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Based on an evaluation carried out as of the end of the period covered by this report, under the supervision and with the participation of our management, our Chief Executive Officer and our Chief Financial Officer concluded that the Company’s “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934) were effective as of September 30, 2016.

Changes in Internal Control over Financial Reporting

The Company is continuously seeking to improve the efficiency and effectiveness of its operations and of its internal control over financial reporting. This is intended to result in refinements to processes throughout the Company.

There were no changes to our internal control over financial reporting, which were identified in connection with the evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Securities Exchange Act of 1934, that occurred during the third quarter of 2016 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II OTHER INFORMATION

Item 1

Legal Proceedings

Legal matters

While we are involved from time to time in claims and legal proceedings that result from, and are incidental to, the conduct of our business including business and commercial litigation, employee and product liability claims, there are no material pending legal proceedings to which the Company or any of its subsidiaries is a party, or of which any of their property is subject. It is possible, however, that an adverse resolution of an unexpectedly large number of such individual claims or proceedings could, in the aggregate, have a material adverse effect on results of operations for a particular year or quarter.

Item 1A

Risk Factors

Information regarding risk factors that could have a material impact on our results of operations or financial condition are described under “Risk Factors” in Item 1A of Part 1 of our 2015 Form 10-K and Item 1A of Part II of our Second Quarter 2016 Form 10-Q. In management’s view, there have been no material changes in the risk factors facing the Company in the quarter.

Item 2

Unregistered Sales of Equity Securities and Use of Proceeds

There have been no unregistered sales of equity securities.

On November 3, 2015 the Company announced that its board of directors has authorized a new share repurchase program which targets to repurchase up to $90 million of common stock over the next three years.

During the three months ended September 30, 2016, no shares of our common stock were repurchased by the Company. There was $82.5 million remaining under the 2015 authorization as at September 30, 2016.

Repurchases of common stock are held as treasury shares unless reissued under equity compensation plans.

Item 3

Defaults Upon Senior Securities

None.

Item 4

Mine Safety Disclosures

Not applicable.

Item 5

Other Information

None.

Item 6

Exhibits


31.1		Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101		XBRL Instance Document and Related Items.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		INNOSPEC INC.
		Registrant

Date: November 3, 2016	By	/s/ PATRICK S. WILLIAMS
		Patrick S. Williams
		President and Chief Executive Officer

Date: November 3, 2016	By	/s/ IAN P. CLEMINSON
		Ian P. Cleminson
		Executive Vice President and Chief Financial Officer

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller reporting company